Samsung's Wearable AI Breakthrough: Heart Monitoring Without the Cloud
New foundation models process ECG-level cardiac data in under a millisecond on smartwatch hardware, keeping health data entirely on-device.

Samsung Research America has introduced two artificial intelligence foundation models that could reshape how wearable devices monitor cardiovascular health. The xMAE and HiMAE models analyze biosignals like electrocardiogram (ECG) and photoplethysmography (PPG) readings directly on smartwatch processors, eliminating the need for cloud processing while delivering what Samsung claims are sub-millisecond inference speeds. Both models have been accepted at premier AI conferences—ICML and ICLR—signaling academic validation of Samsung's technical approach to privacy-preserving health monitoring.
Cross-Modal Learning Reconstructs Missing Cardiac Data
The xMAE (Physiology-Aware Masked Cross-Modal Reconstruction) model addresses a fundamental challenge in wearable health monitoring: continuous PPG sensors are less invasive than ECG but provide less diagnostic precision. Samsung's solution learns temporal relationships between the two signal types, enabling the model to reconstruct missing ECG data from continuous PPG readings captured by optical sensors on the wrist.
According to Samsung researchers, xMAE was trained on approximately 9,400 hours of paired ECG and PPG biosignal data. The model outperformed unimodal and existing multimodal methods in 15 of 19 evaluation tasks, according to Samsung. These tasks spanned cardiovascular disease prediction, abnormal test-result detection, and sleep-stage classification. The model's learned features reportedly transferred across different sensor devices, body locations, and environmental conditions—a critical requirement for real-world wearable deployment where hardware variations and user behavior introduce significant signal variability.
Multi-Timescale Analysis in Real Time
The companion HiMAE (Hierarchical Masked Autoencoder) model tackles another wearable AI constraint: the need to simultaneously analyze millisecond-level heartbeat patterns and hours-to-days biosignal trends without overwhelming limited processor resources. HiMAE uses multiple encoders to process short-burst and long-segment patterns in parallel, achieving what Samsung claims are inference speeds under one millisecond on smartwatch-class CPU hardware.
Samsung reports that a single pretrained HiMAE model handles classification, numerical prediction, and data generation tasks while maintaining a smaller footprint than comparable models. Both xMAE and HiMAE employ self-supervised learning on unlabeled biosignal data—an approach that sidesteps the scarcity of labeled medical datasets that typically constrains health AI development.
Privacy and Platform Implications
The on-device processing architecture keeps biosignal data local to the watch, addressing privacy concerns that have dogged cloud-dependent health monitoring systems. Samsung announced these models as the technical foundation for its Connected Care vision, unveiled at Galaxy Unpacked in July 2026, targeting the Galaxy Watch series.
For healthcare providers, the technology could enable continuous, passive cardiac monitoring at ECG-level precision without requiring patient-initiated measurements—potentially improving early detection of conditions like atrial fibrillation in ambulatory settings. However, questions remain about model performance across diverse demographic populations, battery life implications of continuous on-device inference, and whether the features will achieve medical-grade regulatory clearance from the FDA or equivalent bodies for clinical decision support.
Samsung's vertical integration of sensors, operating system, AI models, and health app ecosystem creates a potential platform for third-party clinical applications, though regulatory pathways for multi-biosignal predictive tools remain unclear. The approach differentiates Samsung from competitors using hybrid on-device/cloud architectures or server-dependent processing, potentially appealing to privacy-conscious consumers and enterprise healthcare partners with strict data governance requirements.
Sources
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.